


Nacerna Life Sciences Revenue
Biotechnology Research • • 1-10 Employees
Nacerna Life Sciences revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Nacerna Life Sciences
Brett Ayers
Director
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Cannabis, Psychedelic Research, Psilocybin, Bioterrorism Countermeasures |
| Employees | 1-10 |
| Socials |
About Nacerna Life Sciences
Nacerna Life Sciences is a Canadian-based biopharmaceutical company driven by innovation and impact. Our mission is to address humanity’s most pressing health challenges through scientific excellence. With decades of combined experience in psychedelics, cannabis therapeutics, finance, and defence, our leadership team brings deep expertise in developing transformative solutions. We are committed to improving lives by advancing psychedelic therapies for mental health conditions like PTSD, delivering premium cannabis-based therapeutics tailored to meet diverse health needs, and creating medical countermeasures that safeguard against chemical and biological threats.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Nacerna Life Sciences has never raised funding before.
Frequently asked questions
4.8
40,000 users



